<DOC>
	<DOCNO>NCT01496820</DOCNO>
	<brief_summary>The effect chitosan blood glucose level contradict . Hypoglycemic effect high molecular weight chitosan relate diabetic model hypoinsulinemia show little effect blood glucose level hyperinsulinemia relate diabetic model . Based previous report , high molecular weight chitosan either directly indirectly relate insulin secretion pancreas little effect insulin resistance . In present study , effect GO2KA1 ( low molecular weight chitosan oligosaccharide ) blood glucose level Korean pre-diabetic adult , evaluate . The change postprandial blood glucose level investigate subject impair fast glucose glucose tolerance .</brief_summary>
	<brief_title>A Randomized Trial Assess Efficacy Safety GO2KA1 ( Chitosan Oligosaccharide ) Blood Glucose Control</brief_title>
	<detailed_description>In detailed description believe wise discus long-term study effect GO2KA1 ( Chitosan oligosaccharide : oligosaccharide derive chitosan ) pre-diabetic individual ( addition postprandial blood glucose level ) . In present study , investigate effect GO2KA1 level postprandial blood glucose adult Koreans impair fast glucose impair glucose tolerance . Postprandial blood glucose level test 2 hour every 30 min interval 75g-OGTT experimental group pre-fed 500 mg GO2KA1 . Primary outcomes include change HbA1c , insulin , glycemic AUC , lipid ( total cholesterol , triglyceride , HDL ) . This clinical study conduct 60 subject explanation accommodation experimental protocol model . To test condition , smoke drinking water completely prohibit 1 hour experiment . At first day , control experiment conduct without oral take GO2KA1 placebo .</detailed_description>
	<mesh_term>Chitosan</mesh_term>
	<criteria>male female 2075 year old impaired fasting glucose ( FPG 100~125 mg/dL ) impair glucose tolerance ( PPG2h 140~200 mg/dL ) able give inform consent receive diagnosis diabetes receive treatment diabetes history ischemic heart disease , stroke , liver cirrhosis , chronic pancreatitis , pituitary disease , thyroid disease , adrenal gland disease , mental illness , gastrectomy , advance malignant tumor receive corticosteroid thyroid hormone medication judge responsible physician local study center unfit participate study abnormal liver kidney function test ( ALT AST &gt; 2 time upper limit normal elevated creatinine , male &gt; 125 umol/L , female &gt; 110 umol/L )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>